BDBM737992 4-cyclopropyl-7-(2-((6- cyclopropyl-1,2,3,4- tetrahydroisoquinolin-7-yl)amino)- 5-(trifluoromethyl)pyrimidin-4-yl)- 3,4-dihydrothieno[2,3- f][1,4]thiazepin-5(2H)-one 1,1- dioxide::US20250144094, Example 224

SMILES O=C1c2sc(-c3nc(Nc4cc5c(cc4C4CC4)CCNC5)ncc3C(F)(F)F)cc2S(=O)(=O)CCN1C1CC1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 737992   

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737992(4-cyclopropyl-7-(2-((6- cyclopropyl-1,2,3,4- tetra...)
Affinity DataIC50: 5nMAssay Description:Table 4: ULK1 inhibitor potency was determined using the luminescent ADP Glo Kinase Assay (Promega), a universal ADP detection system that measures k...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/9/2025
Entry Details
US Patent